A. Ismaila, K. Haeussler, A. Czira, Jung-Hae Youn, M. Malmenäs, N. Risebrough, J. Agarwal, M. Nassim, R. Sharma, C. Compton, C. Vogelmeier, D. Halpin
{"title":"糠酸氟替卡松/乌莫列地铵/维兰特罗(FF/UMEC/VI)与其他三联疗法治疗慢性阻塞性肺疾病(COPD)的疗效比较:系统文献综述和网络meta分析","authors":"A. Ismaila, K. Haeussler, A. Czira, Jung-Hae Youn, M. Malmenäs, N. Risebrough, J. Agarwal, M. Nassim, R. Sharma, C. Compton, C. Vogelmeier, D. Halpin","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2795","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":403586,"journal":{"name":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","volume":"9 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparative Efficacy of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Versus Other Triple Therapies for the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review and Network Meta-Analysis\",\"authors\":\"A. Ismaila, K. Haeussler, A. Czira, Jung-Hae Youn, M. Malmenäs, N. Risebrough, J. Agarwal, M. Nassim, R. Sharma, C. Compton, C. Vogelmeier, D. Halpin\",\"doi\":\"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2795\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":403586,\"journal\":{\"name\":\"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES\",\"volume\":\"9 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2795\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2795","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Comparative Efficacy of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Versus Other Triple Therapies for the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review and Network Meta-Analysis